{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:08:38Z","timestamp":1773252518564,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.therap.2015.12.005","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T10:32:31Z","timestamp":1458297151000},"page":"389-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["M\u00e9thotrexate pour grossesse extra-ut\u00e9rine\u00a0: quels risques en cas de nouvelle grossesse\u00a0?"],"prefix":"10.1016","volume":"71","author":[{"given":"Laurence","family":"Lagarce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silviana","family":"Phelipot-Lates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Perault-Pochat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Drablier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Bourneau-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Lain\u00e9-Cessac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2015.12.005_bib0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jgyn.2014.12.008","article-title":"Evidence-based evaluation and expertise of methotrexate off label use in gynaecology and obstetrics: work of the CNGOF","volume":"44","author":"Marret","year":"2015","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.therap.2015.12.005_bib0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0162-3109(00)00189-2","article-title":"Mechanisms of action of methotrexate","volume":"47","author":"Genestier","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.therap.2015.12.005_bib0145","series-title":"Goodman and Gilman. Les bases pharmacologiques de l\u2019utilisation des m\u00e9dicaments","author":"Hardman","year":"1996"},{"key":"10.1016\/j.therap.2015.12.005_bib0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jgyn.2014.12.011","article-title":"Methotrexate pharmacology","volume":"44","author":"Lagarce","year":"2015","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.therap.2015.12.005_bib0155","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/GRF.0b013e3182510a35","article-title":"Methotrexate: the pharmacology behind medical treatment for ectopic pregnancy","volume":"55","author":"Stika","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.therap.2015.12.005_bib0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/bcp.12209","article-title":"Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types","volume":"77","author":"Korell","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.therap.2015.12.005_bib0165","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1002\/art.24034","article-title":"Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis","volume":"58","author":"Dalrymple","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.therap.2015.12.005_bib0170","unstructured":"Micromedex. Inc, 2014."},{"key":"10.1016\/j.therap.2015.12.005_bib0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2515\/therapie\/2014013","article-title":"Terappel: description of a computerised database and examples of studies","volume":"69","author":"Vial","year":"2014","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2015.12.005_bib0180","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s100249900069","article-title":"Methotrexate-resistant form of dihydrofolate reductase protects transgenic murine embryos from teratogenic effects of methotrexate","volume":"1","author":"Sutton","year":"1998","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.therap.2015.12.005_bib0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdra.23003","article-title":"Teratogen update: methotrexate","volume":"94","author":"Hyoun","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"3","key":"10.1016\/j.therap.2015.12.005_bib0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/tera.1420170314","article-title":"Aminopterin and methotrexate: folic acid deficiency","volume":"17","author":"Warkany","year":"1978","journal-title":"Teratology"},{"issue":"5","key":"10.1016\/j.therap.2015.12.005_bib0195","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.1780400527","article-title":"Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother","volume":"40","author":"Buckley","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.therap.2015.12.005_bib0200","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/tera.1420470605","article-title":"Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy","volume":"47","author":"Feldkamp","year":"1993","journal-title":"Teratology"},{"key":"10.1016\/j.therap.2015.12.005_bib0205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.fertnstert.2011.06.014","article-title":"Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy","volume":"96","author":"Poggi","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.therap.2015.12.005_bib0210","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00246-011-9913-z","article-title":"Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure?","volume":"32","author":"Piggott","year":"2011","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"10.1016\/j.therap.2015.12.005_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.07.002","article-title":"Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic","volume":"205","author":"Nurmohamed","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.therap.2015.12.005_bib0220","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/ajmg.a.36625","article-title":"Maternal exposure to methotrexate and birth defects: a population-based study","volume":"164A","author":"Dawson","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.therap.2015.12.005_bib0225","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","author":"Weber-Schoendorfer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.therap.2015.12.005_bib0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.reprotox.2013.10.005","article-title":"Methotrexate embryopathy after exposure to low weekly doses in early pregnancy","volume":"43","author":"Martin","year":"2014","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.therap.2015.12.005_bib0235","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jacc.2013.07.100","article-title":"Hot topics in tetralogy of Fallot","volume":"62","author":"Villafane","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"Spec no\u00a01","key":"10.1016\/j.therap.2015.12.005_bib0240","first-page":"4","article-title":"Prenatal health in 2002\u20132003. Survey of medical practice. Results from the Audipog sentinel network","volume":"32","author":"Mamelle","year":"2004","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.therap.2015.12.005_bib0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.reprotox.2008.11.055","article-title":"The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy","volume":"27","author":"Svirsky","year":"2009","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.therap.2015.12.005_bib0250","series-title":"Compte rendu de s\u00e9ance du groupe de travail reproduction grossesse et allaitement du 18\u00a0d\u00e9cembre 2014","author":"ANSM","year":"2015"},{"key":"10.1016\/j.therap.2015.12.005_bib0125","series-title":"Perinatal epidemiology","author":"Kline","year":"1984"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T07:53:26Z","timestamp":1554278006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0040595716000500"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2015.12.005","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9thotrexate pour grossesse extra-ut\u00e9rine\u00a0: quels risques en cas de nouvelle grossesse\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}